SS 27 - Breast Cancer 2: Multimodal Strategies in Breast Cancer: Biology, Systemic Therapy, and Psychosocial Insights

Presentations

• 05:00pm - 05:10pm PT

  Acute Toxicity in SWOG 1706, a Randomized Trial Comparing Radiotherapy for Inflammatory Breast Cancer with and without Concurrent Olaparib

  Speaker: Reshma Jagsi, MD, PhD, FASTRO - Emory University School of Medicine, Atlanta
• 05:10pm - 05:20pm PT

  Standard of Care Systemic Treatment with or without Stereotactic Body Radiation Therapy (SBRT) in the Management of Patients with Newly Diagnosed Extra-cranial Oligometastatic Breast Cancer (OMBC): A Prospective Randomized Study (NCT06144346)

  Speaker: Rimoun Boutrus, MD, PhD - National Cancer Institute, Cairo University, Cairo
• 05:20pm - 05:30pm PT

  Association of Circulating Tumor Cell Dynamic Changes during Radiotherapy with Prognosis in Breast Cancer

  Speaker: Xuran Zhao, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing
• 05:30pm - 05:40pm PT

  Past Trauma and Its Effects on Patient Perception during Breast Cancer Radiotherapy

  Speaker: Katherine Gerber, BA - Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia
• 05:40pm - 05:50pm PT

  Safety and potential radiosensitizing effect of Olaparib in combination with breast radiotherapy for TNBC patients with residual disease: long-term results from a phase I trial

  Speaker: Pierre Loap, MD - Institut Curie, Paris
• 05:50pm - 06:00pm PT

  Discussant

  Speaker: Tamer Refaat, MD, PhD, MS - Loyola University Chicago, Chicago